好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Scalp EEG Complexity as a Biomarker of Depression in Unilateral Temporal Lobe Epilepsy
Epilepsy/Clinical Neurophysiology (EEG)
P8 - Poster Session 8 (11:45 AM-12:45 PM)
10-007
This study investigated whether scalp EEG could serve as a potential biomarker of depression in persons with unilateral temporal lobe epilepsy (TLE).

Depression is a common and disabling comorbidity in temporal lobe epilepsy (TLE). Despite its clinical significance, reliable objective biomarkers for depression in TLE remain elusive. In this study, we investigated whether scalp EEG complexity as assessed by sample entropy could serve as a potential biomarker of depression in persons with unilateral TLE.

We analyzed visually normal awake, resting-state scalp EEG from 22 subjects with unilateral TLE who also completed the Beck Depression Inventory-II (BDI-II). Five minutes of visually normal, awake EEG were bandpass filtered (0.5–55 Hz) using a finite impulse response filter, segmented into 1-second epochs, and analyzed for sample entropy (pattern length m = 2, tolerance r = 0.1). For each channel, we computed the mean and standard deviation (SD) of the entropy across epochs.

Nine patients met criteria for depression (BDI-II ≥ 20) and 13 were not depressed (BDI-II < 20). Mean entropy did not differ between the two groups. However, entropy variability (SD) was significantly lower in the depressed group (MANOVA p = 0.002). Regional analysis showed reduced entropy variability in frontal, posterior temporal, and occipital electrodes of the ictal hemisphere and in the posterior temporal region of the non-ictal hemisphere (p < 0.03), with a trend in the non-ictal frontal region (p = 0.07). Across all subjects, reduced variability in entropy in frontal and posterior temporal regions of the ictal hemisphere correlated with higher depression severity (r2 > 0.31, p < 0.007).

Reduced flexibility in EEG complexity within the frontotemporal networks of the epileptogenic hemisphere may serve as a network-level signature of depression in unilateral TLE. Measuring entropy variability provides a non-invasive EEG metric that could enhance clinical evaluation and inform individualized treatment.

Authors/Disclosures
Sookyung Oh, MD (UC Irvine Medical Center)
PRESENTER
Dr. Oh has nothing to disclose.
Victoria Ho, MD, PhD (UCLA Neurology) The institution of Dr. Ho has received research support from NIH.
Doris Deng, MD (Johns Hopkins University) Dr. Deng has nothing to disclose.
Kurt Y. Qing, MD, PhD (New York Presbyterian Hospital, Weill Cornell Medical Center) Dr. Qing has nothing to disclose.
Melanie Lucas, PhD Dr. Lucas has nothing to disclose.
Sumeet Vadera, MD Dr. Vadera has nothing to disclose.
David King-Stephens, MD (University of California, Irvine) Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Mona Sazgar, MD (University of California, Irvine) Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care.
Lilit Mnatsakanyan, MD (UC Irvine Medical Center) Dr. Mnatsakanyan has nothing to disclose.
Diego A. Pizzagalli, PhD Prof. Pizzagalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharmaceuticals. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neumora. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boehringer. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Circular Genomics. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Compass Pathway. Prof. Pizzagalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Engrail. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroscience Software. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Psychonomic Society. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychological Association. Prof. Pizzagalli has stock in Ceretype Neuromedicine. Prof. Pizzagalli has stock in Compass Pathway. Prof. Pizzagalli has stock in Engrail Therapeutics. Prof. Pizzagalli has stock in Neumora Therapeutics. Prof. Pizzagalli has stock in Neuroscience Software.
Beth Lopour The institution of Dr. Lopour has received research support from NIH. The institution of Dr. Lopour has received research support from Department of Defense. The institution of Dr. Lopour has received research support from John C. Hench Foundation. Dr. Lopour has received personal compensation in the range of $500-$4,999 for serving as a grant reviewer with NIH.
Brian Jung, MD Dr. Jung has nothing to disclose.